The National Health Surveillance Agency (Anvisa) reported that, on Monday, 28, a meeting was held with technicians from the agency and the Butantan Institute to discuss the Butanvac vaccine against covid-19. According to the agency, the clinical research protocol is already approved, but there is still a lack of specific data to start the tests in humans.
In a note, the regulatory body states that the purpose of the meeting was to evaluate the information already presented by Butantan. “But for the vaccine to start being applied to human beings, it is necessary to present specific data, which are still being generated by Butantan”, he says. According to Anvisa, an example of the missing data refers to the inactivation of the virus used in the vaccine.
Read Also
- Five good reasons to have tuna May 19, 2020
- Covid, the ‘mask’ in a gel to protect the eyes from the virus Aug 12, 2021
- Covid-19: After a brief lull, the coronavirus epidemic is starting again in France Nov 25, 2022
- FAZ survey: Federal states register great interest in boosting vaccinations Sep 3, 2021
- Chronic Covid N°17 – ” We were many, young and in good health, to be protected by our immunities, innate and/or cross, then why do we have all locked up ? “ Jul 30, 2020
- From Julión Álvarez to Galilea Montijo: which celebrities were linked to drug traffickers and why May 28, 2022
- Named the perfect food for late dinner Jul 15, 2020